
Half-Century Bet on a Fentanyl Vaccine Enters Human Trials
Decades after the idea was first pitched, researchers are testing a fentanyl‑targeting vaccine (Fentanyl Armour) in humans while other teams pursue multivalent vaccines and monoclonal antibodies. Early data show the vaccine is safe and elicits anti‑fentanyl antibodies, but whether enough people develop protective antibody levels and how long protection lasts remain unknown amid funding and political hurdles. The work aims to block fentanyl in the bloodstream before it reaches the brain, offering an overdose‑prevention strategy rather than a cure for addiction.













